EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thymol Impacts the Progression of Endometriosis by Disrupting Estrogen Signaling Pathways and Inflammatory Responses

Yu Zhang, Aftab Shaukat iD, Han Zhang, Yao-Feng Yang, Hui-Xia Li, Guang-Ya Li, Ying-Nan Liu, Chen Liang, Jin-Wen Kang, Shao-Chuan Li iD, Ren-Wei Su iD

International Journal of Molecular Sciences · 07.12.2024 · 25 (23) · 13150

DOI: 10.3390/ijms252313150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.12.2024. Verfasst von Yu Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, South China Agricultural University, Guangzhou 540642, China. Hauptthemen laut MEDLINE: Thymol, Endometriosis, Signal Transduction, Estrogens. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Province Double First-class Discipline Promotion Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis is a chronic inflammatory, estrogenic disorder caused by endometrial tissue growth places other than uterine lumen, resulting in infertility and severe pelvic pain. Thymol, an extract of Thymus vulgaris, processes diverse biological properties, including anti-inflammatory, local anesthetic, decongestant, and antiseptic effects. However, the efficacy of thymol in treating endometriosis has still not been explored. Herein, this research aimed to investigate the role of thymol in the treatment of endometriosis using a murine model and Ishikawa cells. Thirty C57BL/6 mice were administered 17β-E2 (100 ng/mouse) subcutaneously for three consecutive days to induce synchronous estrus. On the last day of injection, the mice underwent surgical induction of endometriosis. After that, the mice were divided into three groups, i.e., Control (CTRL), Thymol 30 mg/kg and Thymol 60 mg/kg, receiving oral administration of either saline or thymol (30 mg/kg/d or 60 mg/kg/d, as 0.1 mL/kg/d, respectively) for a three-week duration. Each group consisted of ten mice and was evenly divided into estrus and diestrus according to the vaginal cytology on the last day of treatment. Thymol significantly (p < 0.05) reduced the weight and volume of ectopic tissue, hindered cell proliferation, and stimulated apoptosis compared to the CTRL group. Additionally, in the thymol-treated group, the levels of pro-inflammatory cytokines, tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6, as well as the numbers of neutrophils and macrophages, were significantly (p < 0.05) decreased. Moreover, a novel role of thymol in rebalancing estrogen and progesterone (E2-P4) signaling was explored, and it was distributed in the ectopic endometrium. Next, the role of thymol on Ishikawa cells was determined. The results demonstrated that thymol significantly (p < 0.05) suppressed the E2-induced proliferation of Ishikawa cells. Furthermore, molecular docking analyses suggested that thymol potentially binds to ESR1-like estrogens, indicating its antagonistic activity against estrogens. The estrogen receptor 1 (ESR1) and its target gene expression exhibited significant (p < 0.05) downregulation, while progesterone receptor (PGR) and target genes were markedly (p < 0.05) upregulated following thymol treatment in the ectopic endometrium. Most importantly, our data revealed the minimal impact of thymol treatment on the eutopic endometrium and its crucial role in supporting pregnancy, thus indicating the safety of thymol in treating endometriosis. Overall, our study suggests that thymol holds promising therapeutic implications for endometriosis by virtue of its anti-inflammatory properties and ability to antagonize estrogen activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThymolEndometriosisSignal TransductionEstrogensFemaleAnimalsMiceHumansInflammationMice, Inbred C57BLDisease Models, AnimalDisease ProgressionCytokinesCell Proliferation

Stichwörter der Autor:innen

endometriosisestrogen signalinginflammationthymol

Substanzen

ThymolEstrogensCytokines

Autor:innen und Institutionen

  • College of Veterinary Medicine, South China Agricultural University, Guangzhou 540642, China.
  • Key Laboratory of Animal Vaccine Development, Ministry of Agriculture, Guangzhou 510642, China.

ORCID-Profile: Aftab Shaukat, Shao-Chuan Li, Ren-Wei Su

Förderung

  • National Natural Science Foundation of China
  • Guangdong Province Double First-class Discipline Promotion Project

Zitieren

APA

Zhang, Y., Shaukat, A., Zhang, H., Yang, Y. F., Li, H. X., Li, G. Y., Liu, Y. N., Liang, C., Kang, J. W., Li, S. C., & Su, R. W. (2024). Thymol Impacts the Progression of Endometriosis by Disrupting Estrogen Signaling Pathways and Inflammatory Responses. International Journal of Molecular Sciences, 25(23), 13150. https://doi.org/10.3390/ijms252313150

Vancouver

Zhang Y, Shaukat A, Zhang H, Yang YF, Li HX, Li GY, et al. Thymol Impacts the Progression of Endometriosis by Disrupting Estrogen Signaling Pathways and Inflammatory Responses. International Journal of Molecular Sciences. 2024;25(23):13150. doi:10.3390/ijms252313150

BibTeX
@article{Zhang2024,
  author = {Zhang, Yu and Shaukat, Aftab and Zhang, Han and Yang, Yao-Feng and Li, Hui-Xia and Li, Guang-Ya and Liu, Ying-Nan and Liang, Chen and Kang, Jin-Wen and Li, Shao-Chuan and Su, Ren-Wei},
  title = {Thymol Impacts the Progression of Endometriosis by Disrupting Estrogen Signaling Pathways and Inflammatory Responses},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {23},
  pages = {13150},
  doi = {10.3390/ijms252313150}
}
Kostenlos starten →